C

Cell Signaling Technology

Antibody development and validated research tools

Full Stack Developer

Full-TimePosted on 10/19/2026
$157k - $222k/yr+ 6% 401(k) match
Senior
Bachelor's
Danvers, MA, USA
In Person
Software EngineeringFull-Stack Engineering

About the job

Requirements
  • A bachelor's degree in Computer Science, Engineering, or a related field, or equivalent experience.
  • At least 5 years of full stack development experience.
  • Proficiency in HTML5, CSS3, JavaScript, and TypeScript.
  • Proficiency in Vue.js Composition API and Nuxt.js.
  • Hands-on experience with a headless CMS platform; Contentstack is strongly preferred, while Contentful, Sanity, or similar platforms are considered.
  • Hands-on experience with a headless or composable commerce platform; CommerceTools is strongly preferred, while similar platforms are considered.
  • Hands-on experience with search infrastructure; Elasticsearch is preferred, while similar platforms are considered.
  • Proficiency in a back-end language such as Node.js, Python, Java, or C#.
  • Experience developing RESTful and/or GraphQL APIs.
  • Strong knowledge of relational databases such as SQL Server, PostgreSQL, or MySQL, and/or NoSQL databases.
  • Familiarity with Git-based version control.
  • Familiarity with AI-assisted development tools such as GitHub Copilot, Claude Code, or Cursor.
  • Understanding of secure coding practices and data protection standards, including OWASP Top 10.
  • Working knowledge of WCAG 2.2 AA accessibility standards and SEO fundamentals.
  • Experience writing automated unit, integration, and end-to-end tests using modern frameworks such as Vitest, Playwright, Cypress, or Jest.
Responsibilities
  • Design, develop, test, and maintain scalable full stack web applications across front-end and back-end systems.
  • Build responsive and intuitive user interfaces using Vue.js and Nuxt.js.
  • Develop and maintain back-end services, APIs, and business logic.
  • Write clean, maintainable, and well-documented code.
  • Build and maintain content models, components, and integrations within Contentstack or the designated headless CMS to support scalable, reusable web experiences.
  • Use AI-assisted development tools such as GitHub Copilot or Claude Code to accelerate delivery while maintaining code quality, security, and test coverage.
  • Participate in code reviews and enforce development standards.
  • Contribute to system architecture decisions and technical design discussions.
  • Design scalable and secure API integrations.
  • Support and evolve a headless, API-first architecture using Contentstack and Nuxt.js/Vue.js to enable content reuse across web properties and channels.
  • Ensure application performance, reliability, and security.
  • Monitor and optimize Core Web Vitals and other web performance benchmarks.
  • Evaluate and recommend new technologies and tools.
  • Design and maintain relational and/or NoSQL databases.
  • Optimize queries and database performance.
  • Develop integrations with third-party systems, including ERP, CRM, analytics, and SaaS platforms.
  • Ensure data integrity and adherence to governance standards.
  • Support CI/CD pipelines and automated deployment processes.
  • Collaborate with DevOps to ensure secure and efficient production releases.
  • Troubleshoot and resolve application defects and performance issues.
  • Partner with Product Owners and business stakeholders to translate requirements into technical solutions.
  • Participate in Agile ceremonies, including sprint planning, stand-ups, and retrospectives.
  • Document technical specifications and processes.
  • Champion web accessibility and SEO best practices across all web properties.
  • Contribute to ongoing improvements in development practices and tooling.
Desired Qualifications
  • Experience with React or Angular.
  • Cloud-platform experience with AWS, Azure, or GCP.
  • Production experience with Vue.js/Nuxt.js in a high-traffic marketing or e-commerce environment.
  • Experience with GraphQL APIs and modern state-management patterns such as Pinia.
  • Familiarity with performance budgets and Core Web Vitals optimization.
  • Experience with component or design systems such as Storybook.
  • Experience supporting multi-region or multi-language websites.
  • Experience in life sciences, healthcare, or another regulated industry.

About the company

C

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 ISO 13485 certification widens CST's regulated manufacturing addressable market.
  • June 2026 Quantum-Si partnership ties CST to next-generation proteomics validation.
  • 2026 deals with Leveragen, MJFF, and Nordic Biosite expand distribution and disease-specific demand.

What critics are saying

  • Antibody catalogs commoditize fast; Thermo Fisher and Abcam pressure CST pricing by 2027.
  • WuXi Diagnostics partnership concentrates diagnostic ambitions inside one CDx channel and regulatory bottleneck.
  • A prolonged research funding slump would choke orders and expose CST's existential dependence on academia.

What makes Cell Signaling Technology unique

  • Scientists still own CST, preserving assay credibility and product discipline.
  • ISO 13485 certification covers Beverly and Leiden, strengthening regulated reagent manufacturing.
  • SignalStar and proprietary antibody platforms keep CST embedded across spatial biology workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Company Match
  • Tuition Reimbursement
  • Unlimited Paid Time Off
  • Parental Leave
  • Employee Assistance Program
  • Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

28%

1 year growth

28%

2 year growth

28%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.